Global Multiple Sclerosis Treatment Market Report 2023:
Dublin, May 03, 2023 (GLOBE NEWSWIRE) -- The "Global Multiple Sclerosis Treatment Market Report and Forecast 2023-2031" report has been added to ...
Source: globenewswire.com
Stay updated with breaking news from Multiple Sclerosis Drug. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dublin, May 03, 2023 (GLOBE NEWSWIRE) -- The "Global Multiple Sclerosis Treatment Market Report and Forecast 2023-2031" report has been added to ...
Novartis settled with some of the drugmakers it had sued, allowing for some Gilenya generics before a key patent's 2027 expiration.
This decision confirms the validity of the Gilenya patent and allows that injunction to remain in place, Novartis said